Get notified when OTLK files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: OTLK Outlook Therapeutics, Inc. 8-K

Outlook Therapeutics raises capital via 8.5M share registered direct offering to single investor

Filed May 29, 2026 · Period ending May 29, 2026 · ~1 min read

Key Changes

  • high

    Company sold 8,539,709 common shares to GMS Ventures and Investments in a registered direct offering under existing shelf registration statement from April 2024.

  • high

    Single-investor placement completed May 28-29, 2026, representing significant dilution to existing shareholders depending on offering price and current share count.

    8-K: Securities Purchase Agreement verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade OTLK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · May 29, 2026 · How we verify